Piroska Klement

775 total citations
8 papers, 123 citations indexed

About

Piroska Klement is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Piroska Klement has authored 8 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 1 paper in Molecular Biology and 1 paper in Genetics. Recurrent topics in Piroska Klement's work include Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Acute Lymphoblastic Leukemia research (1 paper). Piroska Klement is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Acute Lymphoblastic Leukemia research (1 paper). Piroska Klement collaborates with scholars based in Germany and Czechia. Piroska Klement's co-authors include Jonathan D. Cooper, J.W.D. McDonald, Michael Heuser, Arnold Ganser, Felicitas Thol, Razif Gabdoulline, Gudrun Göhring, Joerg Heineke, Badder Kattih and Robert Geffers and has published in prestigious journals such as Blood, Leukemia and Cancers.

In The Last Decade

Piroska Klement

7 papers receiving 113 citations

Peers

Piroska Klement

HEMAT

MB

CCM

PRM

IMMUN

Mohamed Sami Mourali Tunisia

Elena Abad Spain

Xue Feng China

Zacharoula Nikolakopoulou United Kingdom

Luisa Averdunk Germany

P. Rumpf Germany

Paul Anaya United States

Richard Varcoe United Kingdom

Iria Beltrán Rodríguez Spain

Miho Miyoshi Japan

Mohamed Sami Mourali Tunisia

Piroska Klement

11 ×0.3

HEMAT

27 ×0.8

MB

76 ×3.3

CCM

29 ×1.3

PRM

14 ×0.8

IMMUN

Citations per year, relative to Piroska Klement Piroska Klement (= 1×) peers Mohamed Sami Mourali

Countries citing papers authored by Piroska Klement

Since Specialization

Citations

This map shows the geographic impact of Piroska Klement's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piroska Klement with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piroska Klement more than expected).

Fields of papers citing papers by Piroska Klement

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piroska Klement. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piroska Klement. The network helps show where Piroska Klement may publish in the future.

Co-authorship network of co-authors of Piroska Klement

This figure shows the co-authorship network connecting the top 25 collaborators of Piroska Klement. A scholar is included among the top collaborators of Piroska Klement based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piroska Klement. Piroska Klement is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Stadler, Michael, Razif Gabdoulline, Piroska Klement, et al.. (2023). MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML. Cancers. 15(15). 3911–3911. 5 indexed citations

2.

Shahswar, Rabia, Gernot Beutel, Razif Gabdoulline, et al.. (2023). Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia. Haematologica. 109(1). 72–83. 10 indexed citations

3.

Klement, Piroska, Walter Fiedler, Jürgen Krauter, et al.. (2023). Prognostic Impact of Clonality of Myelodysplasia-Related Gene Mutations in AML. Blood. 142(Supplement 1). 817–817. 1 indexed citations

4.

Klement, Piroska, Walter Fiedler, Jürgen Krauter, et al.. (2022). Prognostic Impact of Clonal Hierarchy of Myelodysplasia-Related Gene Mutations in AML Patients. Blood. 140(Supplement 1). 6254–6255.

5.

Kattih, Badder, Piroska Klement, Abel Martin Garrido, et al.. (2020). IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis. Leukemia. 35(5). 1301–1316. 37 indexed citations

6.

Kattih, Badder, Piroska Klement, Abel Martin Garrido, et al.. (2020). IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML. Blood. 136(Supplement 1). 32–33. 1 indexed citations

7.

Tesařová, Markéta, Hana Hansíková, Piroska Klement, et al.. (2002). [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families].. PubMed. 141(17). 551–4. 1 indexed citations

8.

Cooper, Jonathan D., et al.. (1980). Prostaglandin production associated with the pulmonary vascular response to complement activation.. PubMed. 88(2). 215–21. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact